Completed
The Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration fosters the adoption of innovative technologies by pharmaceutical companies. To assist CDER in those efforts, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will produce a consensus report that identifies emerging and upcoming technologies that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by CDER.
Featured publication
Innovations in Pharmaceutical Manufacturing on the Horizon: Proceedings of a Workshop—in Brief
Proceedings
·2022
Emerging technologies have the potential to modernize pharmaceutical manufacturing and advance the quality of drug products. A 2021 report from the National Academies of Sciences, Engineering, and Medicine (the National Academies) identified these innovative technologies, including manufacturing pro...
View details
Publications
Discover
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
NAS Building Guided Tours Available!
Participate in a one-hour guided tour of the historic National Academy of Sciences building, highlighting its distinctive architecture, renowned artwork, and the intersection of art, science, and culture.